[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hims & Hers Health Inc (HIMS)

Hims & Hers Health Inc (HIMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,325,646
  • Shares Outstanding, K 231,458
  • Annual Sales, $ 2,348 M
  • Annual Income, $ 128,370 K
  • EBIT $ -31 M
  • EBITDA $ 26 M
  • 60-Month Beta 2.40
  • Price/Sales 3.17
  • Price/Cash Flow 38.43
  • Price/Book 16.63

Options Overview Details

View History
  • Implied Volatility 97.50% (-4.46%)
  • Historical Volatility 96.57%
  • IV Percentile 65%
  • IV Rank 56.19%
  • IV High 127.22% on 10/16/25
  • IV Low 59.38% on 12/31/25
  • Expected Move (DTE 1) 0.84 (2.84%)
  • Put/Call Vol Ratio 0.64
  • Today's Volume 58,433
  • Volume Avg (30-Day) 88,787
  • Put/Call OI Ratio 0.64
  • Today's Open Interest 896,961
  • Open Int (30-Day) 923,353
  • Expected Range 28.77 to 30.45

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 15 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.07
  • Number of Estimates 3
  • High Estimate $-0.01
  • Low Estimate $-0.16
  • Prior Year $0.17
  • Growth Rate Est. (year over year) -141.18%

Price Performance

See More
Period Period Low Period High Performance
1-Month
24.24 +22.36%
on 07/30/26
38.59 -23.14%
on 07/07/26
-8.62 (-22.52%)
since 07/06/26
3-Month
21.53 +37.76%
on 05/19/26
39.05 -24.05%
on 07/06/26
+2.78 (+10.34%)
since 05/06/26
52-Week
13.74 +115.87%
on 02/24/26
65.30 -54.58%
on 10/15/25
-21.47 (-41.99%)
since 08/06/25

Most Recent Stories

More News
Kaplan Fox Reminds Investors of Hims & Hers Health, Inc. (NYSE: HIMS) of an Ongoing Investigation Into Potential Securities Law Violations

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

BAC : 63.00 (-0.40%)
HIMS : 29.66 (-6.29%)
Hims & Hers Introduces New Hers App with First-of-Its-Kind, Doctor-Led, AI-Native Care Experience

Rebuilt from the ground up, the new Hers app puts women in one continuous conversation with their providers, Care Teams, and AI, delivering personalized weight loss support the moment she needs it

HIMS : 29.66 (-6.29%)
NYSE: HIMS Investigation Reminder: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm

RADNOR, Pa. , Aug. 5, 2026 /PRNewswire/ -- Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ), a nationally recognized securities litigation law firm, is investigating potential violations of...

HIMS : 29.66 (-6.29%)
The FTC Is Suing Hims & Hers Health—Here's Why Investors Shouldn't Panic

Hims & Hers Health shares have rallied despite an FTC lawsuit over data sharing and billing practices, as weight-loss drug partnerships and Wall Street's cautious Hold rating shape the stock's outlook...

META : 589.90 (+0.19%)
HIMS : 29.66 (-6.29%)
NVO : 45.97 (+3.23%)
LLY : 1,191.94 (+1.89%)
SNAP : 5.22 (-2.06%)
Kaplan Fox is Investigating Hims & Hers Health, Inc. (NYSE: HIMS) for Potential Securities Law Violations - Investors are Encouraged to Contact the Firm

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

BAC : 63.00 (-0.40%)
HIMS : 29.66 (-6.29%)
NYSE: HIMS Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm

Kessler Topaz Meltzer & Check, LLP ( www.ktmc.com ), a nationally recognized securities litigation law firm, is investigating potential violations of the federal securities laws by Hims &...

HIMS : 29.66 (-6.29%)
Bearish Pressure Is Building Around These 3 Stocks

Hims & Hers Health and QXO face heavy short interest amid dilution and loss concerns, while KLA has slid nearly 40% since June as AI-driven chip spending fears grip semiconductor stocks.

KLAC : 193.22 (+0.22%)
TSLA : 319.53 (-0.63%)
HIMS : 29.66 (-6.29%)
NVO : 45.97 (+3.23%)
QXO : 15.18 (-4.53%)
SKHY : 143.53 (-4.97%)
1 Russell 2000 Stock with Exciting Potential and 2 We Ignore

1 Russell 2000 Stock with Exciting Potential and 2 We Ignore

SSTK : 5.91 (-5.29%)
HIMS : 29.66 (-6.29%)
RNST : 43.30 (-1.88%)
Kaplan Fox Encourages Investors of Hims & Hers Health, Inc. (NYSE: HIMS) to Contact the Firm Regarding an Investigation Into Possible Securities Law Violations

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

BAC : 63.00 (-0.40%)
HIMS : 29.66 (-6.29%)
HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with SBS Law

LOS ANGELES , July 31, 2026 /PRNewswire/ -- Schall, Brown & Schwartz  LLP ("SBS"), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors...

HIMS : 29.66 (-6.29%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree...

See More

Key Turning Points

3rd Resistance Point 33.62
2nd Resistance Point 33.02
1st Resistance Point 32.33
Last Price 29.66
1st Support Level 31.05
2nd Support Level 30.45
3rd Support Level 29.76

See More

52-Week High 65.30
Fibonacci 61.8% 45.60
Fibonacci 50% 39.52
Fibonacci 38.2% 33.44
Last Price 29.66
52-Week Low 13.74

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.